An international collaboration led by Hilleman Laboratories has confirmed the launch of a new oral cholera vaccine called ...

The expansion aims to meet the company’s rapidly growing need for in-house biologics manufacturing, with an emphasis on ...

Results from a phase 2 trial of the candidate schizophrenia drug, currently known as NBI-1117568, show that it met the ...

Just months after facing a rejection in the US, the bispecific antibody odronextamab (Ordspono) has been approved by the ...

Microbiotica has received the green light from EU and UK regulatory authorities to start phase 1b studies for its microbiome ...

The US FDA has granted emergency use authorization to several updated COVID-19 vaccines against a new viral strain that is ...

ImmPACT Bio has received FDA clearance to start clinical trials for its CD19/CD20 bispecific CAR-T cell therapy in multiple ...

Eisai and Biogen’s new Alzheimer’s treatment, lecanemab, received a green light from UK regulators, marking a significant ...

In the rapidly evolving field of drug discovery, Melanie Adams-Cioaba stands at the forefront, leading transformative advancements in cryo-electron microscopy (cryo-EM) at Thermo Fisher Scientific.

The US FDA has granted approval to Niktimvo for the treatment of chronic graft-versus-host disease, a serious immune ...

As antibody-drug conjugates (ADCs) continue to heat up in the industry, Adcendo of Denmark has gained the global rights from ...

In a promising advancement, scientists from the University of North Carolina at Chapel Hill and Emory University have ...